BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2100453)

  • 1. [Value of squamous cell epithelial-associated (SCC-) antigens in early diagnosis of oral carcinoma].
    Zöller J; Mende U; Fiehn W
    ZWR; 1990 Dec; 99(12):981-2, 984-5. PubMed ID: 2100453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results with the use of the SCC antigen in squamous cell carcinomas of the oral cavity].
    Hellner D; Klapdor R; Gundlach KH; Schmelzle R
    Dtsch Z Mund Kiefer Gesichtschir; 1989; 13(4):291-5. PubMed ID: 2637079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The diagnostic value of the tumor markers CEA, "Ca 19-9", "Ca 125", "Ca15-3" and "SCC" for the detection of recurrent tumors in patients with tumors of the head and neck].
    Zöller J; Fiehn W; Mende U; Hotz G
    Dtsch Z Mund Kiefer Gesichtschir; 1990; 14(4):254-9. PubMed ID: 2134649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of tumor markers in patients with squamous cell carcinoma in the oral cavity.
    Kurokawa H; Tsuru S; Okada M; Nakamura T; Kajiyama M
    Int J Oral Maxillofac Surg; 1993 Feb; 22(1):35-8. PubMed ID: 7681461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of SCC-Ag, CEA, CA 19.9 and CA 125 for diagnosis and follow-up in oral cancer.
    Krimmel M; Hoffmann J; Krimmel C; Cornelius CP; Schwenzer N
    J Craniomaxillofac Surg; 1998 Aug; 26(4):243-8. PubMed ID: 9777503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of preoperative squamous cell carcinoma antigen in oral-cavity squamous cell carcinoma.
    Lin WH; Chen IH; Wei FC; Huang JJ; Kang CJ; Hsieh LL; Wang HM; Huang SF
    Laryngoscope; 2011 May; 121(5):971-7. PubMed ID: 21520110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination assay for tumor markers in oral squamous cell carcinoma.
    Kurokawa H; Yamashita Y; Tokudome S; Kajiyama M
    J Oral Maxillofac Surg; 1997 Sep; 55(9):964-6. PubMed ID: 9294507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Squamous cell carcinoma antigen in oral squamous cell carcinomas.
    Nagumo K; Okada N; Takagi M; Yamamoto H; Amagasa T; Fujibayashi T
    Bull Tokyo Med Dent Univ; 1990 Jun; 37(1-2):27-34. PubMed ID: 2225283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Squamous cell carcinoma antigen in the diagnosis and treatment follow-up of oral and facial squamous cell carcinoma.
    Fischbach W; Meyer T; Barthel K
    Cancer; 1990 Mar; 65(6):1321-4. PubMed ID: 2306680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Squamous cell carcinoma antigen in the serum of oromaxillary cancer.
    Yoshimura Y; Harada T; Oka M; Sugihara T; Kishimoto H
    Int J Oral Maxillofac Surg; 1988 Feb; 17(1):49-53. PubMed ID: 3127492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of serum levels of SCC antigen in cancers of the oral cavity].
    Yoshida H; Kinehara M; Sato K
    Gan To Kagaku Ryoho; 1989 Nov; 16(11):3595-601. PubMed ID: 2817910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using SCC antigen and CRP levels as prognostic biomarkers in recurrent oral cavity squamous cell carcinoma.
    Chen IH; Liao CT; Wang HM; Huang JJ; Kang CJ; Huang SF
    PLoS One; 2014; 9(7):e103265. PubMed ID: 25061977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [SCC (squamous cell carcinoma) antigen as a tumor marker in cervix cancers].
    Geyer H; Schwörer D; Pfleiderer A
    Geburtshilfe Frauenheilkd; 1989 Mar; 49(3):266-71. PubMed ID: 2721888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early diagnosis and treatment monitoring roles of tumor markers Cyfra 21-1 and TPS in oral squamous cell carcinoma.
    Nagler RM; Barak M; Peled M; Ben-Aryeh H; Filatov M; Laufer D
    Cancer; 1999 Mar; 85(5):1018-25. PubMed ID: 10091783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk stratification in oral cavity squamous cell carcinoma by preoperative CRP and SCC antigen levels.
    Huang SF; Wei FC; Liao CT; Wang HM; Lin CY; Lo S; Huang JJ; Chen IH; Kang CJ; Chien HT; Chen HH
    Ann Surg Oncol; 2012 Nov; 19(12):3856-64. PubMed ID: 22576068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of the serum HER-2/neu and squamous cell carcinoma-related antigen expression in patients with oral squamous cell carcinoma.
    Chen CH; Tsai TL; Yang YS; Tsai CC
    J Oral Pathol Med; 2007 Feb; 36(2):83-7. PubMed ID: 17238969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Diagnostic and Prognostic Value of Tumor Markers (CEA, SCC, CYFRA 21-1, TPS) in Head and Neck Cancer Patients.
    Barak V; Meirovitz A; Leibovici V; Rachmut J; Peretz T; Eliashar R; Gross M
    Anticancer Res; 2015 Oct; 35(10):5519-24. PubMed ID: 26408719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Squamous cell carcinoma-associated antigen in uroepithelial carcinoma.
    Tsukamoto T; Kumamoto Y; Ohmura K; Miyao N; Nammbu A; Takagi Y; Itoh N
    Urology; 1992 Nov; 40(5):477-83. PubMed ID: 1441052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relevance of the new tumor marker SCC (squamous cell carcinoma antigen) for the diagnosis and follow-up control of squamous epithelial carcinoma of the head and neck].
    Koch T; Eiffert H; Spindler MB
    HNO; 1989 Nov; 37(11):454-9. PubMed ID: 2584067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The SCC antigen is not a reliable tumor marker in the ENT area. Value of squamous cell carcinoma antigen in diagnosis and follow-up of squamous epithelial carcinoma in the head-neck area. Results of a retrospective study over 6 years].
    Gotschuli A; Anderhuber W; Danninger R; Habermann W
    Laryngorhinootologie; 1998 Mar; 77(3):165-7. PubMed ID: 9577824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.